-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Fast Track Designation to MapLight Therapeutics' ML-007C-MA for Alzheimer's Psychosis

Reuters·01/05/2026 12:00:25

Please log in to view news